RBMS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.441600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.594800E-01
Normal-vs-Stage2
4.085800E-01
Normal-vs-Stage3
3.437200E-01
Normal-vs-Stage4
6.054800E-01
Stage1-vs-Stage2
9.225200E-01
Stage1-vs-Stage3
5.287400E-01
Stage1-vs-Stage4
9.131400E-01
Stage2-vs-Stage3
5.158800E-01
Stage2-vs-Stage4
8.453800E-01
Stage3-vs-Stage4
4.173400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.636000E-01
Normal-vs-AfricanAmerican
4.156400E-01
Normal-vs-Asian
2.808400E-01
Caucasian-vs-AfricanAmerican
9.071800E-01
Caucasian-vs-Asian
3.549400E-01
AfricanAmerican-vs-Asian
6.386200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.671600E-01
Normal-vs-Female
3.400000E-01
Male-vs-Female
8.501400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.473600E-01
Normal-vs-Age(41-60Yrs)
6.701600E-01
Normal-vs-Age(61-80Yrs)
2.393000E-01
Normal-vs-Age(81-100Yrs)
4.424200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.562600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.879000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.460800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.435300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.383200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.863600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.540560E-01
Normal-vs-Daily Drinker
1.214600E-01
Normal-vs-Weekly Drinker
2.541800E-01
Normal-vs-Occasional Drinker
5.307200E-01
Normal-vs-Social Drinker
4.087200E-01
Non Drinker-vs-Daily Drinker
8.788800E-01
Non Drinker-vs-Weekly Drinker
7.308000E-01
Non Drinker-vs-Occasional Drinker
1.537980E-01
Non Drinker-vs-Social Drinker
2.105000E-01
Daily Drinker-vs-Weekly Drinker
6.355800E-01
Daily Drinker-vs-Occasional Drinker
1.295620E-01
Daily Drinker-vs-Social Drinker
1.621040E-01
Weekly Drinker-vs-Occasional Drinker
3.742600E-01
Weekly Drinker-vs-Social Drinker
4.348200E-01
Occasional Drinker-vs-Social Drinker
8.563800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.172200E-01
Normal-vs-Grade 2
2.457900E-02
Normal-vs-Grade 3
1.596210E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.701100E-03
Grade 1-vs-Grade 3
3.876200E-03
Grade 1-vs-Grade 4
2.172200E-01
Grade 2-vs-Grade 3
3.533200E-01
Grade 2-vs-Grade 4
2.457900E-02
Grade 3-vs-Grade 4
1.596210E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.175000E-01
Normal-vs-NonDiabetic
3.193200E-01
Diabetic-vs-NonDiabetic
5.351800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.424800E-01
Normal-vs-NoPancreatitis
2.477000E-01
Pancreatitis-vs-NoPancreatitis
1.937180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.548400E-01
Normal-vs-N1
4.162600E-01
N0-vs-N1
1.785040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.159600E-01
Normal-vs-TP53-NonMutant
2.058600E-01
TP53-Mutant-vs-TP53-NonMutant
4.358800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
